Suffer the Little Children in the Research for Cures_USA Today Thu, 29 May 2003 USA Today focuses on safety issues affecting children who are being sought as human guinea pigs by the thousands. They are being recruited clinical trials to test new . . . Continue reading →
non-consensual
Don’t Medicate Away Student Angst – Chronicle Higher Ed
Don’t Medicate Away Student Angst – Chronicle Higher Ed Sun, 15 Jun 2003 The Chronicle of Higher Education has published a superb essay by Joli Jensen, a professor of communications from the University of Tulsa. Jensen recognizes the harmful effects of medicating . . . Continue reading →
AHRP Comments – Precursors to Diabetes in Japanese American Youth
ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) August 21, 2002 Comments Re: DHHS Notice of Proposed Recommendation Regarding Support of Research Protocol: "Precursors to Diabetes in Japanese American Youth" Grant Number I R01 DK59234-01 The proposed experiment would involve 450 children healthy children, . . . Continue reading →
Infomail Archive
Infomail 2004 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Dec 31: FDA to review “missing” drug company documents Dec 30: Family of Woman Killed by AIDS Drug Test Sues Doctors, Manufacturer Dec 30: Doctors, Too, Ask: Is . . . Continue reading →
Israeli State Comptroller Blasts Researchers for Experimenting on Patients without Consent
Israeli State Comptroller Blasts Researchers for Experimenting on Patients without Consent Tue, 26 Jul 2005 Patients the world over need adeaquate protection from overreaching physicians who use patients to test experimental drugs and procedures without their informed consent. Jacques Michel, a retired . . . Continue reading →
Depressed? NYC Mental Screens in Search of People at Risk – NY Times
Depressed? NYC Screens for People at Risk – NY Times Wed, 13 Apr 2005 A front page article in The New York Times reports that the New York City Department of Health and Mental Hygiene, has instructed doctors at City hospitals – . . . Continue reading →
Anatomy of an Epidemic: Psychiatric Drugs and the Astonishing Rise of Mental Illness in America – Whitaker
Anatomy of an Epidemic: Psychiatric Drugs and the Astonishing Rise of Mental Illness in America by Robert Whitaker, Ethical Human Psychology and Psychiatry, Volume 7, Number I , Spring 2005 Mon, 29 Aug 2005 Some uncritical promoters of psychiatry and its current . . . Continue reading →
Former FDA Chief Lied Under Oath Is Charged With Financial Conflict of Interest
Below the New York Times provides a summary of Crawford's selective disclosure and concealment of his financial holdings while he was
Commissioner, noting Crawford's ignoble tenure:
Continue reading →
OHRP Response to AHRP Complaint & AHRP Reply
Did OHRP conduct an investigation of the PolyHeme blood experiment and did OHRP issue a report of its findings?
Continue reading →
AHRP Files Federal Complaint Re: Non-Consensual “Blood Substitute” Experiment on Trauma Patients
This controversial, commercial experiment is being conducted without informed consent in trauma patients who require blood to survive. PolyHeme is being tested in patients in ambulances and at hospital emergency facilities where these trauma patients are denied life-saving real blood.
Continue reading →
Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations
THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org Proposed Changes to Subpart D Regulations Increase Risks to Children in Non-Therapeutic Research Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations April 18, 2005 The Alliance for Human Research Protection (AHRP) welcomes . . . Continue reading →
Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations
The Alliance for Human Research Protection (AHRP) welcomes the opportunity to respond to the question “What is the Best Way to Protect Children?”
Our recommendation – which is backed up by evidence that children have suffered harm in medical research – is to significantly limit the discretion of IRBs to approve greater than minimal risk research without direct benefit for the child-subjects under 46.406.
We recommend staying the course in requiring that any such proposed experiment undergo a transparent open evaluation with ample opportunity for public oversight and comment – as required under the provisions of 46.407.